Cellcept and Walking pneumonia - a phase IV clinical study of FDA data

Summary:

Walking pneumonia is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Microscopic polyangiitis.

The phase IV clinical study analyzes which people have Walking pneumonia when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Walking pneumonia?

Walking pneumonia (atypical pneumonia not caused by one of the more traditional pathogen) is found to be associated with 581 drugs and 941 conditions by eHealthMe. Check the latest studies of Walking pneumonia.

On Apr, 05, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 19 people (0.05%) have Walking pneumonia.

Among these 19 people:

How long have people been on Cellcept when they have Walking pneumonia? *

What is the gender of people who have Walking pneumonia when taking Cellcept? *

female: 68.42 %
male: 31.58 %

What is the age of people who have Walking pneumonia when taking Cellcept? *

What are other drugs people take besides Cellcept? *

What are other side effects people have besides Walking pneumonia? *

Fever: 13 people, 68.42%
Dyspnea (difficult or laboured breathing): 12 people, 63.16%
Haemoglobin Decreased: 9 people, 47.37%
Red Blood Cell Count Decreased: 6 people, 31.58%
Haematocrit Decreased: 6 people, 31.58%
Cardiac Failure: 5 people, 26.32%
Renal Disorder (kidney disease): 5 people, 26.32%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 26.32%
Blood Pressure Systolic Increased: 5 people, 26.32%
Hypotension (abnormally low blood pressure): 5 people, 26.32%

What are the existing conditions these people have? *

Vasculitis (inflammation of a blood vessel or blood vessels): 5 people, 26.32%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 26.32%
Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 5 people, 26.32%
High Blood Pressure: 3 people, 15.79%
Immunodeficiency Disorders: 2 people, 10.53%
Cellulitis (infection under the skin): 2 people, 10.53%
Cytomegalovirus Infection: 2 people, 10.53%
Enlarged Prostate: 2 people, 10.53%
Glomerulonephritis Chronic (long lasting group of conditions that affect parts of the kidneys called glomeruli): 2 people, 10.53%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Walking pneumonia?

- Check whether Walking pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Walking pneumonia:

Walking pneumonia (581 drugs)

Browse all the conditions that are associated with Walking pneumonia:

Walking pneumonia (941 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.